Brolucizumab

ATC S01LA06 · 9 markets · 15 records

Brolucizumab 9 markets · 15 records Forms

AU 5 records · 3 strengths

  • 120 mg/mLinjectionBEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vialBEOVU brolucizumab (rbe) 120 mg/mL solution for injection in pre-filled syringe、VSIQQ brolucizumab (rbe) 120 mg/mL solution for injection in vial unknown
  • 6 mg/0.05 mLinjectionBEOVU also in US

Records without a stated strength · 1 BEOVU

CA 2 records · 1 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 BEOVU SOLUTION FOR INJECTION 6MG/0.05ML、BEOVU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 6MG/0.05ML

    US 1 records · 1 strengths

    • 6 mg/0.05 mLinjectionBEOVU also in AU

    GB 1 records · 1 strengths

    • 19.8 mg/0.165 mLinjectionBeovu 19.8mg/0.165ml solution for injection pre-filled syringes

    ES 1 records · 1 strengths

    MX 1 records · 1 strengths

      Records without a stated strength · 1 VSIQQ

      TW 1 records · 1 strengths

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 BEOVU

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.